Tomer Kariv

Tomer Kariv is a declared insider at 3 companies; the most frequent names are Arno Therapeutics, Inc, Keros Therapeutics, Inc. and Eloxx Pharmaceuticals, Inc. Between 12 January 2016 and 4 June 2025, the trades on record add up to 6 filings.

No open-market sale appears; the market trades are 4 purchases worth €1.4M. The totals exclude 3 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants.

Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 6 June 2025, reports a share grant in Keros Therapeutics, Inc. The last purchase on record was published on 17 May 2021, which is 1,980 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.